Evidence map›Paper›PMID 34443529›Full record

ReviewMolecules (Basel, Switzerland)2021

Bee Venom: From Venom to Drug.

Abdelwahab Khalil, Basem H Elesawy, Tarek M Ali, Osama M Ahmed

Open access · goldAbstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed, 1 pooled it
9.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 1 synthesis or guideline pooled it, 96 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Physico-Chemical and Mineral Variability ofMolecules (Basel, Switzerland) · 2026
    Article
  5. Review
  6. Review
  7. Review
  8. AnCurrent medicinal chemistry · 2026
    Article
  9. Article
  10. Exploratory proteomic characterization ofFrontiers in pharmacology · 2026
    Article
  11. Therapeutic Bioactivity Exerted by theMolecules (Basel, Switzerland) · 2025
    Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. The Anti-Leukemic Potential of Bee Venom.International journal of general medicine · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Abdelwahab KhalilEntomology Division, Zoology Department, Faculty of Science, Beni-Suef University, Beni-Suef 62521, Egypt.
Basem H ElesawyDepartment of Clinical Laboratory Sciences, College of Applied Medical Sciences, Taif University, P.O. Box 11099, Taif 21944, Saudi Arabia.
Tarek M AliDepartment of Physiology, College of Medicine, Taif University, P.O. Box 11099, Taif 21944, Saudi Arabia.ORCID 0000-0002-2998-247X
Osama M AhmedPhysiology Division, Zoology Department, Faculty of Science, Beni-Suef University, Beni-Suef 62521, Egypt.ORCID 0000-0003-3781-9709
Beni-Suef University · EGMansoura University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Insects of the order Hymenoptera have a defensive substance that contains many biologically active compounds. Specifically, venom from honeybees (

Indexed as

AllergensAnimalsBeesBee VenomsEnzymesHumansInsect Bites and StingsPeptidesPharmaceutical PreparationsAllergensBee VenomsEnzymesPeptidesPharmaceutical Preparationsbee venombee venom productsinflammatory and chronic diseasesnanoparticles

Identifiers

PMID34443529
PMCPMC8400317
OpenAlexW3193703245

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.